In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...

In terms of its financial performance, Novo Nordisk's bread and butter are its therapies for type 2 diabetes (Ozempic) and obesity (Wegovy); both are the same molecule, semaglutide, which works by ...

Hopewell man arrested for restaurant robbery is also a murder suspect in Colonial Heights “The facility will provide small molecule API ... including Ozempic and Wegovy. Ozempic is used ...

Back in May, Novo unveiled full results from its FLOW trial showing that a once-weekly 1-mg dose of semaglutide—the molecule behind Ozempic and Wegovy—helped combat major kidney outcomes like ...

In contrast, HS-10535 is a small molecule drug, which ... as well as sibling medicines like its drug Wegovy for treating obesity, if Merck's weight loss candidate is easier to make, it could ...